Tokyo Tape
Sign in
← Medinet

Quarterly report · Q3

2370.TEDINET S100RNR9
Period2022-10-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥492m2022-10-01 → 2023-06-30StandaloneNet sales
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales (5-year summary)
Revenue¥470m2021-10-01 → 2022-06-30StandaloneNet sales
Operating income−¥1.0bn2022-10-01 → 2023-06-30StandaloneOperating income
Operating income−¥988m2021-10-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥1.0bn2022-10-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥984m2021-10-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥1.0bn2022-10-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥985m2021-10-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥1.0bn2022-10-01 → 2023-06-30StandaloneProfit loss
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneNet income loss (5-year summary)
Net income−¥989m2021-10-01 → 2022-06-30StandaloneProfit loss
Total assets¥5.5bnat 2023-06-30StandaloneAssets
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥6.3bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥564mat 2023-06-30StandaloneLiabilities
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Net assets / equity¥5.0bnat 2023-06-30StandaloneNet assets
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥5.7bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.1bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
EPS (basic)¥-4.92022-10-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.72023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.112021-10-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.52022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio89.3%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.4%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued219,986,757at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-06-30−¥445m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2022-10-01 → 2023-06-30¥358,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2022-10-01 → 2023-06-30¥358,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2022-10-01 → 2023-06-30−¥359m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2022-10-01 → 2023-06-30¥492m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2022-10-01 → 2023-06-30¥492m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2022-10-01 → 2023-06-30−¥242m
—segment totalrevenue2022-10-01 → 2023-06-30¥492m
—segment totalrevenue external2022-10-01 → 2023-06-30¥492m
—segment totalsegment profit2022-10-01 → 2023-06-30−¥601m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-06-30−¥386m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥425m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥178m
—segment totalrevenue2021-10-01 → 2022-06-30¥470m
—segment totalrevenue external2021-10-01 → 2022-06-30¥470m
—segment totalsegment profit2021-10-01 → 2022-06-30−¥603m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 321
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember469590000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember194000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember469785000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember469785000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember-177589000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember-424998000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember-602587000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember-385818000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-988406000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember491563000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember358000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember491922000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember491922000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember491563000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember358000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember491922000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember491922000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember-242092000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember-358860000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-600953000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-445412000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-1046366000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第28期第３四半期（自　2023年４月１日　至　2023年６月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社メディネット
Company name in english cover pageFilingDateInstantMEDINET Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　久布白　兼直
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都品川区勝島一丁目５番21号（同所は登記上の本店所在地であり、実際の業務は「最寄りの連絡場所」で行っております。）
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都大田区平和島六丁目１番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)（０３）６６３１－１２０１（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役経営管理部長　落合　雅三
Place for public inspection cover page (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass